BRTX vs ED · rev $401.0K vs P/E 18, rev $15.26B
BioRestorative Therapies Inc (BRTX) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
BRTX currently screens at market cap $10.2M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the BRTX and ED stock pages for the full models.
Not investment advice.